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Abstract
VevoVitall® is a feed additive consisting of benzoic acid. It is currently authorised as a zootechnical
additive for weaned piglets and pigs for fattening. This opinion concerns the renewal of the
authorisation of benzoic acid as a zootechnical additive in feed. In 2005 and 2017, the EFSA Panel on
Additives and Products or Substances used in Animal Feed (FEEDAP) adopted two opinions on the safety
and efﬁcacy of VevoVitall® as a feed additive for weaned piglets and pigs for fattening, respectively. The
applicant has provided data demonstrating that the additive currently in the market complies with the
conditions of authorisation. Furthermore, according to the information provided in the technical dossier,
no new evidence has been identiﬁed that would make the FEEDAP Panel reconsidering the previous
conclusions on the safety of the additive. The Panel conﬁrms that the additive is safe at the maximum
authorised concentrations of 5,000 and 10,000 mg/kg feed for weaned piglets and pigs for fattening,
respectively; a margin of safety cannot be determined for weaned piglets while a margin of safety of less
than 1.5 is established for pigs for fattening. The use of VevoVitall® in feeds for weaned piglets and pigs
for fattening at the maximum authorised concentrations does not pose any safety concern for
consumers and the environment. The use of VevoVitall® does not pose a risk by inhalation to users and
is not a skin sensitiser. The new available data conﬁrm that the additive is a skin irritant and a severe eye
irritant. A recommendation concerning the potential toluene residues in the additive has been posted.
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1. Introduction
1.1. Background and Terms of Reference
Regulation (EC) No 1831/20031 establishes the rules governing the Community authorisation of
additives for use in animal nutrition. In particular, Article 14(1) of that Regulation lays down that an
application for renewal shall be sent to the Commission at the latest one year before the expiry date of
the authorisation.
The European Commission received a request from DSM Nutritional Products AG2 for renewal of the
authorisation of the product VevoVitall® (Benzoic Acid), when used as a feed additive for weaned
piglets and pigs for fattening (category: zootechnical additives; functional group: other zootechnical
additives).
According to Article 7(1) of Regulation (EC) No 1831/2003, the Commission forwarded the
application to the European Food Safety Authority (EFSA) as an application under Article 14(1)
(renewal of the authorisation). The particulars and documents in support of the application were
considered valid by EFSA as of 21 June 2016.
According to Article 8 of Regulation (EC) No 1831/2003, EFSA, after verifying the particulars and
documents submitted by the applicant, shall undertake an assessment in order to determine whether
the feed additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on
the safety for the target animals, consumer, user and the environment and on the efﬁcacy of the
product VevoVitall® (benzoic acid), when used under the proposed conditions of use (see
Section 3.1.3).
1.2. Interpretation of the Terms of Reference
The application for renewal of the authorisation does not include a proposal for amending or
supplementing the conditions of the original authorisation that would have an impact on the efﬁcacy of
the additive; therefore, efﬁcacy is not assessed. The present opinion will focus only on the safety
aspects.
1.3. Additional information
The FEEDAP Panel has adopted a total of six opinions on the safety and efﬁcacy of VevoVitall® for
weaned piglets (EFSA, 2005; EFSA FEEDAP Panel, 2011), pigs for fattening (EFSA, 2007) and pigs for
reproduction (EFSA FEEDAP Panel, 2012, 2015) and minor porcine species (EFSA FEEDAP Panel,
2017).
The product from the applicant, either as VevoVitall® or as benzoic acid, is authorised in the European
Union (EU) as a zootechnical additive for weaned piglets at the content of 5,000 mg/kg complete
feedingstuffs,3,4 and for pigs for fattening5 and sows6 at the maximum content of 10,000 mg/kg
complete feedingstuffs.
2. Data and methodologies
2.1. Data
The present assessment is based on data submitted by the applicant in the form of a technical
dossier7 in support of the authorisation request for the use of VevoVitall® (benzoic acid) as a feed
1 Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in
animal nutrition. OJ L 268, 18.10.2003, p. 29.
2 DSM Nutritional Products AG represented in the EU by DSM Nutritional Products Sp. z o.o. Poland: Tarczynska 113, 96-320
Mszczonow, Poland.
3 Commission Regulation (EC) No 1730/2006 of 23 November 2006 concerning the authorisation of benzoic acid (VevoVitall) as a
feed additive. OJ L 325, 24.11.2006, p. 9.
4 Commission Implementing Regulation (EU) No 226/2012 of 15 March 2012 amending Regulation (EC) No 1730/2006 as
regards the conditions of use of benzoic acid (holder of authorisation Emerald Kalama Chemical BV). OJ L 77, 16.3.2012, p. 6.
5 Commission Regulation (EC) No 1138/2007 of 1 October 2007 concerning the authorisation of benzoic acid (VevoVitall) as a
feed additive. OJ L 265, 2.10.2007, p. 8.
6 Commission Implementing Regulation (EU) 2016/900 of 8 June 2016 concerning the authorisation of benzoic acid as a feed
additive for sows (holder of authorisation DSM Nutritional Product Sp. z o. o.). OJ L 152, 9.6.2016, p. 18.
7 FEED dossier reference: FAD-2015-0044.
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additive. The technical dossier was prepared following the provisions of Article 14 of Regulation (EC)
No 1831/2003, Regulation (EC) No 429/20088 and the applicable EFSA guidance documents.
The FEEDAP Panel used the data provided by the applicant together with data from other sources,
such as previous risk assessments by EFSA or other expert bodies to deliver the present output.
The European Union Reference Laboratory (EURL) considered that the conclusions and
recommendations reached in the previous assessment are valid and applicable for the current
application.9
2.2. Methodologies
The approach followed by the FEEDAP Panel to assess the safety of VevoVitall® (benzoic acid) is in
line with the principles laid down in Regulation (EC) No 429/2008 and the relevant guidance
document: Guidance on the renewal of the authorisation of feed additives (EFSA FEEDAP Panel, 2013).
3. Assessment
This assessment regards the renewal of the authorisation of the product VevoVitall® (≥ 99.9%
benzoic acid) as a zootechnical additive, functional group ‘other zootechnical additives’, to be used in
feedingstuffs for weaned piglets at 5,000 mg/kg complete feed and pigs for fattening at the minimum
and maximum content of 5,000 and 10,000 mg/kg complete feed, respectively. The speciﬁc functions
under which the authorisation is granted is:
• for weaned piglets, ‘improvement of performance parameters: weight gain or feed/gain ratio’,
and
• for pigs for fattening, ‘urinary pH decrease’.
3.1. Characterisation
3.1.1. Characterisation of the product
The additive VevoVitall® contains benzoic acid (benzenecarboxylic acid, phenylcarboxylic acid,
Chemical Abstracts Service (CAS) No 65–85–0, European Inventory of Existing Commercial Chemical
Substances (EINECS) No 200–168–2) as an active substance.
The manufacturing process of benzoic acid is based on the oxidation of toluene.10 The applicant
states that the manufacturing process meets the principles described in the primary authorisation with
no changes. The process includes the checking for toluene residues; however, no analytical data and
speciﬁcations for toluene are present.
The speciﬁcations of the additive as deﬁned by the applicant are: ≥ 99% benzoic acid, ≤ 100 mg/kg
phthalic acid, ≤ 100 mg/kg sum of biphenyls, ≤ 10 mg/kg heavy metals (as lead) and ≤ 2.0 mg/kg
arsenic. These speciﬁcations meet those described in the authorisation of VevoVitall®. Moreover, these
speciﬁcations are consistent with those described for benzoic acid as a food additive (Commission
Directive 96/77/EC)11. The analysis of six batches of the additive showed that benzoic acid from
VevoVitall® met the speciﬁcations regarding benzoic acid content and impurities: benzoic acid > 99%;
phthalic acid 25–36 mg/kg; biphenyls 63–66 mg/kg; heavy metals < 10 mg/kg; arsenic < 0.01 mg/kg;
sulfated ash < 0.01%.12
The product appears as white ﬂakes. The analysis of particle size distribution was made by dry
sieving13 and laser diffraction.14 The results showed that virtually all particles had a diameter greater
than 425 lm; no particles below 50 lm were detected by laser diffraction. The applicant also provided
8 Commission Regulation (EC) No 429/2008 of 25 April 2008 on detailed rules for the implementation of Regulation (EC)
No 1831/2003 of the European Parliament and of the Council as regards the preparation and the presentation of applications
and the assessment and the authorisation of feed additives. OJ L 133, 22.5.2008, p. 1.
9 The report linked to the previous dossier (related to EFSA-Q-2010-00881) is available on the EURL website: https://ec.
europa.eu/jrc/sites/default/files/FinRep-FAD-2010-0029.pdf
10 Technical dossier/Supplementary information/Appendix 02.
11 Commission Directive 96/77/EC of 2 December 1996 laying down speciﬁc purity criteria on food additives other than colours
and sweeteners. OJ L 339, 30.12.1996, p. 1.
12 Technical Dossier/Section II/Annex_II_6. Complementary Information-August 2017. Values reported as «<» refer to the limit
of quantiﬁcation.
13 Technical Dossier/Section II/Annex_II_7.
14 Technical Dossier/Supplementary Information/Appendix 06.
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an evaluation of the ﬁgures obtained by sieving with those from the product analysed in 2010,
showing that the results were comparable.
The dusting potential, determined by the Stauber–Heubach test in the same three batches in which
the sieve analysis was done (see paragraph above), was 0.04 g/m3.13,14
3.1.2. Stability and homogeneity
By means of analysis of benzoic acid, the shelf-life of 24 months, the stability in premixtures of
6 months and the stability in feed of 3 months and the stability to pelleting have been already
demonstrated.15,16 A further study in pig pelleted feed (pelleting temperature 85°C) stored at 25°C for
12 months demonstrated that no losses of benzoic acid during pelleting and storage of the feed were
observed.17
The ability for VevoVitall® to mix homogeneously is the same as in the primary authorisations as its
particles size and composition are unchanged.
3.1.3. Conditions of use
VevoVitall® is currently authorised for use in weaned piglets at the maximum dose of 5,000 mg/kg
complete feed and in pigs for fattening at the minimum dose of 5,000 mg/kg complete feed and at the
maximum dose of 10,000 mg/kg complete feed. No modiﬁcation of the authorised conditions of use is
proposed. The authorisation prescribes that the permitted maximum level for benzoic acid in complete
feed should not be exceeded, accounting for the different sources of contribution.
Indications on the use of the additive in complementary feed are provided in the authorisation:
Complementary feedingstuffs containing benzoic acid shall not be fed to pigs as such and should be
thoroughly mixed with other feed materials of the daily ration. Measures to protect users including the
use of breathing protection and gloves are also foreseen.
3.2. Safety
The applicant performed a literature search in order to provide evidence that in the light of the
current knowledge the additive remains safe under the approved conditions for target species,
consumers, users/workers and the environment. Details of the literature search performed are given
later, in each speciﬁc safety subsection.18
3.2.1. Safety for the target species
Six scientiﬁc opinions on VevoVitall® concluded that the additive is safe in weaned piglets (EFSA,
2005; EFSA FEEDAP Panel, 2011), pigs for fattening (EFSA, 2007), pigs for reproduction (EFSA FEEDAP
Panel, 2012, 2015) and minor porcine species (EFSA FEEDAP Panel et al., 2017) when used as a
zootechnical additive at a dose between 5,000 and 10,000 mg/kg complete feed. The FEEDAP
Panel had identiﬁed an increase of adverse effects, and in particular of oesophagus and gastric lesions,
at excess concentrations of benzoic acid in feeds – higher than 5,000 and 10,000 mg/kg in piglets and
pigs for fattening, respectively (EFSA, 2005, 2007). A margin of safety could not be determined for
weaned piglets; a (narrow) margin of safety of less than 1.5 was calculated for pigs for fattening.
The applicant performed a structured literature search on the safety of the additive for piglets and
growing ﬁnishing pigs. The databases consulted were Scopus and PubMed; the search period covered
from January 2012 to August 2015; the keywords used were: for the substance ‘benzoic or benzoate
or hippuric’, for the target species ‘pig or pigs or swine or piglet or piglets’, for the issue ‘safety or
toxicity or lesions’. A total of 16 publications (see Appendix A) ﬁtted with the search criteria; no paper
reported effects of safety concern related to the supplementation of benzoic acid in pigs at the
concentrations in feeds authorised in the EU.19
The FEEDAP Panel considers that there are no new data that would lead to the revision of the
conclusions on the safety for weaned piglets and pigs for fattening.
15 Technical Dossier/Supplementary Information/Appendix 03.
16 Technical Dossier/Supplementary Information/Appendix 04.
17 Technical Dossier/Supplementary Information/Appendix 05.
18 Technical Dossier/Section III.
19 Technical Dossier/Section III/Annex_III_6.
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3.2.2. Safety for the consumer
In its previous opinions, the FEEDAP Panel did not identify any safety concern for consumers when
VevoVitall® is used in pig feeds at the authorised usage levels.
In order to check if there were new data requiring a revision of the previous conclusions on the
safety for the consumers, the applicant examined three databases (STN/RTECS, Scopus and ToxNet/
ToxLine) and performed two literature searches in different periods: one from 2011 to 2013 and
another from 2012 to 2015.20 In general, the following keywords were used: ‘benzoic acid’,
‘CASREGNUMBER 65-85-0’, ‘genotoxicity’, ‘toxicity’, ‘reproduction toxicity’, ‘allergy’, ‘mutagenicity’,
‘carcinogenicity’. A total of 22 references were extracted, from which 17 related to safety for
consumers and 5 to safety for users (see Appendix A).
No new information related to toxicokinetics or toxicology of benzoic acid was present, with the
exception of genotoxicity. A number of studies published in the open literature report the results of
genotoxicity tests on benzoic acid or its salts (sodium or potassium benzoate). These studies are
described below.
Benzoic acid was found to be genotoxic in comet assays in human lymphocytes (Demir et al., 2010;
Yilmaz et al., 2014) and in haemocytes of Drosophila melanogaster (Demir and Kaya, 2013). However,
it should be considered that these assays are not currently used in regulatory risk assessment and no
OECD guidelines exist for them.
Pongsavee (2015) reported increased micronuclei and chromosomal aberrations in human bone
marrow cells at the concentrations of 1,000 and 2,000 lg sodium benzoate/mL, but in this study no
information on cytotoxicity is given. The study was conducted only without metabolic activation.
Sodium and potassium benzoate caused dose-related increases of sister chromatid exchanges,
micronuclei and chromosomal aberrations in human lymphocytes at all concentrations tested (6.25–
100 lg/mL and 62.5–100 lg/L, respectively, for sodium and potassium benzoate); sodium, but not
potassium benzoate, also increased DNA breaks according to the comet assay. However signiﬁcant
cytotoxicity was reported at all concentrations tested, as indicated by signiﬁcantly reduced mitotic
index (Zengin et al., 2011).
Overall, the results conﬁrm previous assessments that benzoic acid and its derivatives may induce
genotoxic changes in vitro; however, in vivo genotoxicity studies are consistently negative (EFSA
FEEDAP Panel, 2012; EFSA ANS Panel, 2016).
Benzoic acid was also tested in the US EPA’s ToxCast project, a large screening programme using a
panel of high-throughput cell-free assays for CYP activation/inhibition or binding to membrane
receptors (mitochondria, norepinephrine, dopaminergic, aminergic, etc.) as well as nuclear receptors
(e.g. oestrogen): benzoic acid was consistently negative in all assays, indicating a low likelihood to
exert organ/system-speciﬁc toxicity (Sipes et al., 2013).
In conclusion, the review of these studies did not yield information that would require modiﬁcation
of the previous EFSA conclusions and of the position of the Scientiﬁc Committee for Food (SCF)
(European Commission, 2002a) and the Scientiﬁc Committee for Animal Nutrition (SCAN) (European
Commission, 2002b). Therefore, the use of VevoVitall® in weaned piglets and pigs for fattening at the
authorised doses is considered safe for the consumer.
3.2.3. Safety for the user
In its assessment of 2002, the SCAN concluded that benzoic acid is an irritant for the skin and
eyes; microscopic lung lesions were observed in a subacute inhalation test in the rat at the lowest
dose tested of 25 mg/m3, thus a no observed adverse effect concentration (NOAEC) by inhalation was
not identiﬁed (European Commission, 2002b). The SCAN recommended that measures should be taken
to minimise the production of respirable dust; the Committee also concluded that the balance of
evidence in skin sensitisation indicated minimal risk to operators.
User safety was further considered in two EFSA Scientiﬁc opinions on the use of VevoVitall® in
weaned piglets and pigs for fattening (EFSA 2005, 2007). The FEEDAP Panel supported the overall
SCAN position and recommendations. The Panel additionally noted at the time that, whereas benzoic
acid was negative in laboratory assays on skin sensitisation, it induced allergic skin or respiratory
reactions, albeit at low incidence, in sensitised individuals.
20 Technical Dossier/Section III/Annex_III_7.
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VevoVitall® is unlikely to give rise to an appreciable inhalation exposure, since the particle fraction
of inhalable size (≤ 100 lm) represents about 0.6% and particles of the respirable fraction (≤ 10 lm
and below) are virtually absent; the dusting potential is very low (0.04 g/m3) (see Section 3.1.1).
From the literature search provided by the applicant – the same used for the safety for the
consumers (see Section 3.2.2) – ﬁve references related to the safety for the user were identiﬁed (see
Appendix A). Schnuch et al. (2011) performed an analysis of skin sensitisation by preservatives,
including also sodium benzoate, in a large population (over 70,000 subjects) in the United Kingdom;
the frequency of reactions to sodium benzoate was 0.69%. This ﬁnding supports the previous FEEDAP
Panel conclusions that allergy-like reactions to benzoic acid may occur in a small population subset.
The Committee for Risk Assessment of the European Chemicals Agency (ECHA) concluded in 2012
that benzoic acid should be classiﬁed as Eye Damage 1 and Skin Irritant 2.21 The hazard for the eyes
was assigned on the basis of two guideline-based in vivo studies on rabbits, which showed that
benzoic acid powder to be moderately to severely irritating to the eye. Although two guideline-based
in vivo studies on rabbits indicated absent or slight skin irritation, available human data show that
benzoic acid is capable of inducing non-immunological contact urticaria; this lesion is regarded as an
irritation reaction without requiring previous sensitisation. Accordingly, benzoic acid was not considered
as a skin sensitiser. To the best knowledge of the FEEDAP Panel, there are no new data that may
modify the conclusions of the ECHA assessment. The FEEDAP Panel therefore considers that allergy-
like (urticarial) reactions observed in humans upon skin contact with benzoic acid and derivatives do
not have an immunological basis and are manifestations of skin irritation.
The FEEDAP Panel concludes that the use of VevoVitall® does not pose a risk by inhalation to users
and is not a skin sensitiser. The new available data conﬁrm that the additive is a skin irritant and a
severe eye irritant. The additive has low dustiness and a minimal fraction of respirable or inhalable
dust; thus inhalation exposure is considered as very low. No risk to users by inhalation is foreseen at
the conditions of use.
3.2.4. Safety for the environment
Most benzoic acid administered to farm animals will be excreted as urinary hippuric acid (Baldwin
et al., 1960; Kristensen et al., 2009), an endogenous metabolic by-product. Small amounts of
benzoates may also occur in the excreta; such compounds have low potential for adverse effects in
aquatic or terrestrial organisms. SCAN concluded that, based on the characteristics of benzoic acid and
of its metabolites, no concerns for environment are expected (European Commission, 2002b). In 2007,
the FEEDAP Panel endorsed this conclusion for VevoVitall® (EFSA, 2007).
The applicant provided a literature search to support the safety for the environment of the additive,
in accordance with the Guidance for renewal (EFSA FEEDAP Panel, 2013). Two scientiﬁc database were
examined (Scopus and Pubmed) applying two sets of keywords in two different time periods (January
2012–August 2015, keywords: benzoic acid, benzoate, hippuric, air, soil, water, environment, safety22;
January 2012–July 2016, keywords: benzoic, benzoate, hippuric, environmental toxicity, ecotoxicity23)
with the aim of examining if there were new ﬁndings on the safety of benzoic acid for the
environment. A total of 473 references were overall retrieved; however, the large majority of them
were not relevant (e.g. references concerning pesticides, pesticide metabolites or parabens which
contains benzoic acid or hippuric acid-related chemical moieties, occupational toxicity, petroleum
industry). A total of 10 papers (see Appendix A) were deemed to be potentially relevant to the safety
of benzoic acid for the environment, and in particular to the use in animal nutrition, and thus, were
examined further. However, the FEEDAP Panel found that no studies directly relevant to the
environmental risk assessment of benzoic acid were identiﬁed.
Therefore, the references provided do not add any signiﬁcant information to the environmental
safety of benzoic acid used as a feed additive, which may lead to modify the previous conclusion of
the FEEDAP Panel. Accordingly, the Panel considers that there is not new data that call for a revision of
the conclusions on the safety for the environment.
21 Technical Dossier/Section III/Appendix 3–9.
22 Technical Dossier/Section III/Annex_III_12.
23 Technical Dossier/Supplementary Information/Appendix 07.
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3.3. Post-market monitoring
The FEEDAP Panel considers that there is no need for speciﬁc requirements for a post-market
monitoring plan other than those established in the Feed Hygiene Regulation24 and Good
Manufacturing Practice.
4. Conclusions
The applicant has provided data demonstrating that the additive currently in the market complies
with the conditions of authorisation.
The FEEDAP Panel conﬁrms that the use of VevoVitall® is safe at the maximum authorised
concentrations of 5,000 and 10,000 mg/kg feed for weaned piglets and pigs for fattening, respectively;
a margin of safety cannot be determined for weaned piglets while a (narrow) margin of safety of less
than 1.5 is established for pigs for fattening.
The FEEDAP Panel conﬁrms its previous conclusion that the use of VevoVitall® in feeds for weaned
piglets and pigs for fattening at the maximum authorised concentrations does not pose any safety
concern for consumers.
The FEEDAP Panel concludes that the use of VevoVitall® does not pose a risk by inhalation to users
and is not a skin sensitiser. The new available data conﬁrm that the additive is a skin irritant and a
severe eye irritant.
The FEEDAP Panel conﬁrms its previous conclusion that the use of VevoVitall® in feeds for weaned
piglets and pigs for fattening at the maximum authorised concentrations does not pose any concern
for the environment.
5. Recommendations
Toluene impurities in the additive should be monitored during the production process to check the
compliance with the criteria laid by VICH (Veterinary International Cooperation on Harmonisation of
technical requirements for registration of medicinal products) on residual solvents in products for
veterinary use.25
Documentation provided to EFSA
1) Dossier VevoVitall® for pigs for fattening and weaned piglets. December 2015. Submitted by
DSM Nutritional Products Ltd.
2) Dossier VevoVitall® for pigs for fattening and weaned piglets. Supplementary information.
September 2016. Submitted by DSM Nutritional Products Ltd.
3) Dossier VevoVitall® for pigs for fattening and weaned piglets. Complementary information.
August 2017. Submitted by DSM Nutritional Products Ltd.
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